Impact of Cross-Reference Pricing on Pharmaceutical Prices: Manufacturers' Pricing Strategies and Price Regulation

ISSN： 1175-5652

Source： Applied Health Economics and Health Policy, Vol.5, Iss.4, 2006-01, pp. : 235-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is Required to Evaluate the Impact of Pharmaceutical Reference Pricing?

By Puig-Junoy Jaume

Applied Health Economics and Health Policy, Vol. 4, Iss. 2, 2005-01 ,pp. : 87-98

Adis International

Access to resources Recommend Favorite

Review of the literature on reference pricing

By Lopez-Casasnovas G. Puig-Junoy J.

Health Policy, Vol. 54, Iss. 2, 2000-11 ,pp. : 87-123

Elsevier

Access to resources Recommend Favorite

The German experience in reference pricing

By Giuliani G. Selke G. Garattini L.

Health Policy, Vol. 44, Iss. 1, 1998-04 ,pp. : 73-85

Elsevier

Access to resources Recommend Favorite

The Emerging Role of the Consumer in Pharmaceutical Pricing Decisions

By Chumney E.C.

Disease Management & Health Outcomes, Vol. 10, Iss. 4, 2002-01 ,pp. : 229-232

Adis International

Access to resources Recommend Favorite

What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?

By Schneeweiss S. Schoffski O. Selke G.W.

Health Policy, Vol. 44, Iss. 3, 1998-06 ,pp. : 253-260

Elsevier

Access to resources Recommend Favorite